Cantitate/Preț
Produs
Total produse
Vezi coșul
Epstein Barr Virus Volume 2: One Herpes Virus: Many Diseases de Christian Münz

Epstein Barr Virus Volume 2: One Herpes Virus: Many Diseases: Current Topics in Microbiology and Immunology, cartea 391

Editat de Christian Münz
en Limba Engleză Hardback – 14 oct 2015
Epstein Barr virus (EBV) was discovered as the first human tumor virus around 50 years ago. Since its discovery in Burkitt’s lymphoma it has been associated with various other malignancies, infectious mononucleosis and even autoimmune diseases. The two book volumes on EBV summarize the first 50 years of research on this tumor virus, starting with historical perspectives on discovery, oncogenicity and immune control, reviewing the role that the virus plays in the various associated diseases and concluding with a discussion on how the immune system keeps persistent EBV infection under control in healthy EBV carriers and can be used to treat EBV associated diseases. The respective 32 chapters are written by international experts from three continents for health care providers, biomedical researchers and patients that are affected by EBV. The assembled knowledge should help to understand EBV associated diseases better and to develop EBV specific vaccination in the near future.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 108356 lei  43-57 zile
  Springer International Publishing – 23 aug 2016 108356 lei  43-57 zile
Hardback (1) 110037 lei  22-36 zile
  Springer International Publishing – 14 oct 2015 110037 lei  22-36 zile

Din seria Current Topics in Microbiology and Immunology

  • Hantaviruses
    Preț: 38779 lei
  • 18% Epstein Barr Virus Volume 1: One Herpes Virus: Many Diseases
    Preț: 94253 lei
  • Marburg- and Ebolaviruses: From Ecosystems to Molecules
    Preț: 49976 lei
  • 5% Type IV Secretion in Gram-Negative and Gram-Positive Bacteria
    Preț: 31970 lei
  • 5% Coordinating Organismal Physiology Through the Unfolded Protein Response
    Preț: 31742 lei
  • 5% mRNA Vaccines
    Preț: 96779 lei
  • 18% Viral Fitness and Evolution: Population Dynamics and Adaptive Mechanisms
    Preț: 109595 lei
  • 5% T Cell Hybridomas: A Workshop at the Basel Institute for Immunology
    Preț: 70252 lei
  • 5% Tumorviruses, Neoplastic Transformation and Differentiation
    Preț: 69855 lei
  • 5% Current Topics in Microbiology and Immunology: Volume 102
    Preț: 69516 lei
  • 5% Retroviruses 1
    Preț: 69516 lei
  • 5% New Developments in Diagnostic Virology
    Preț: 70662 lei
  • 5% Mouse Mammary Tumor Virus
    Preț: 35255 lei
  • 5% Retroviruses 2
    Preț: 69749 lei
  • 5% Methylation of DNA
    Preț: 75914 lei
  • 15% The Molecular Biology of Adenoviruses I: 30 Years of Adenovirus Research 1953–1983
    Preț: 62711 lei
  • 5% The Molecular Biology of Adenoviruses 2: 30 Years of Adenovirus Research 1953–1983
    Preț: 70252 lei
  • 5% The Molecular Biology of Adenoviruses 3: 30 Years of Adenovirus Research 1953–1983
    Preț: 35310 lei
  • 5% Retroviruses 3
    Preț: 69338 lei
  • 5% Oncogenes in B-Cell Neoplasia: Workshop at the National Cancer Institute, National Institutes of Health, Bethesda, MD, USA, March 5–7, 1984
    Preț: 70306 lei
  • 5% Current Topics in Microbiology and Immunology
    Preț: 70180 lei
  • 5% Human T-Cell Leukemia Virus
    Preț: 70271 lei
  • 5% Iridoviridae
    Preț: 69695 lei
  • 5% The Biology of Trypanosomes
    Preț: 69749 lei
  • 5% Genetic Approaches to Microbial Pathogenicity
    Preț: 70377 lei
  • 5% Images of Biologically Active Structures in the Immune System: Their Use in Biology and Medicine
    Preț: 69516 lei
  • 5% Parasite Antigens in Protection, Diagnosis and Escape
    Preț: 36242 lei
  • 5% Bacteria and Complement
    Preț: 69785 lei
  • 5% The BALB/c Mouse: Genetics and Immunology
    Preț: 70196 lei
  • 5% Retroviruses 4
    Preț: 69233 lei
  • 5% Genetic Control of the Susceptibility to Bacterial Infection
    Preț: 69715 lei
  • 5% Protein Secretion and Export in Bacteria
    Preț: 69911 lei
  • 5% Specificity and Function of Clonally Developing T Cells
    Preț: 70592 lei
  • 5% The Wild Mouse in Immunology
    Preț: 71077 lei
  • 5% Current Topics in Microbiology and Immunology 128
    Preț: 69375 lei
  • 5% Current Topics in Microbiology and Immunology
    Preț: 69928 lei
  • 5% Peptides as Immunogens
    Preț: 69157 lei
  • 5% The Molecular Biology of Baculoviruses
    Preț: 69658 lei
  • 5% Mechanisms in B-Cell Neoplasia: Workshop at the National Cancer Institute, National Institutes of Health, Bethesda, MD,USA,March 24–26,1986
    Preț: 70931 lei
  • 5% Arenaviruses: Genes, Proteins, and Expression
    Preț: 69338 lei
  • 5% Arenaviruses: Biology and Immunotherapy
    Preț: 70090 lei
  • 5% Differentiation of B Lymphocytes
    Preț: 69552 lei
  • 5% The Molecular Biology of Bacterial Virus Systems
    Preț: 35183 lei
  • 5% Genetics of Immunological Diseases
    Preț: 36669 lei
  • 15% Carbohydrate-Protein Interaction
    Preț: 62248 lei
  • 5% Cytotoxic Effector Mechanisms
    Preț: 69356 lei
  • 5% Mechanisms in B-Cell Neoplasia 1988: Workshop at the National Cancer Institute, National Institutes of Health, Bethesda, MD, USA, March 23–25, 1988
    Preț: 70735 lei
  • 15% Human Retrovirology: Facts and Concepts
    Preț: 62008 lei

Preț: 110037 lei

Preț vechi: 115829 lei
-5% Nou

Puncte Express: 1651
Preț estimativ în valută:
21059€ • 21875$ • 17492£

Carte disponibilă

Livrare economică 13-27 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319228334
ISBN-10: 3319228331
Pagini: 505
Ilustrații: VI, 505 p.
Dimensiuni: 155 x 235 x 27 mm
Greutate: 1.13 kg
Ediția:1st ed. 2015
Editura: Springer International Publishing
Colecția Springer
Seria Current Topics in Microbiology and Immunology

Locul publicării:Cham, Switzerland

Public țintă

Research

Cuprins

Preface.- EBV latency.- Chap. 1. EBNA1 – Lori Frappier, University of Toronto, Canada.- Chap. 2. EBNA2 and its coactivator EBNA-LP – Bettina Kempkes, Helmholtz Center Munich, Germany, and Paul D. Ling, Baylor College of Medicine, Houston, USA.- Chap. 3. The EBNA3 family: two oncoproteins and a tumour suppressor that are central to the biology of EBV in B cells– Martin J. Allday, Quentin Bazot and Robert E. White, Imperial College London, UK. Chap. 4. The latent membrane protein 1 (LMP1) – Arnd Kieser and Kai R. Sterz, Helmholtz Center Munich, Germany. Chap. 5. Latent membrane protein 2 (LMP2) – Osman Cen and Richard Longnecker, Northwestern University, Chicago, USA. Chap. 6. EBV non-coding RNAs – Rebecca L. Skalsky and Bryan R. Cullen, Duke University, Durham, USA.- E. Lytic EBV infection.- 7. Viral entry – Liudmila S. Chesnokova, Ru Jiang1 and Lindsey M. Hutt-Fletcher, Louisiana State University, Shreveport, USA.- Chap. 8. Epstein Barr virus lytic cycle reactivation – Jessica McKenzie and Ayman El-Guindy, Yale University, New Haven, USA.- Immune responses to EBV.- Chap. 9. Innate immune recognition of EBV – Anna Lünemann and David Nadal, University of Zürich, Switzerland and Martin Rowe, University of Birmingham, UK.- Chap. 10. Epstein-Barr virus specific humoral immune responses in health and disease – Jaap M. Middeldorp, VU Medical Center, Amsterdam, The Netherlands.- Chap. 11. T cell responses to EBV – Andrew D. Hislop and Graham S. Taylor, University of Birmingham, UK.- Chap. 12. Immune evasion by Epstein Barr virus – Maaike E. Ressing, Michiel van Gent, Anna M. Gram, Marjolein Hooykaas, Sytse Piersma and Emmanuel Wiertz, Utrecht Medical Center, The Netherlands.- Animal models of EBV infection.- Chap. 13. Non-human primate lymphocryptoviruses: past, present, and future– Janine Mühe and Fred Wang, Harvard University, Boston, USA. Chap.14. EBV infection of mice with reconstituted human immune system components –
Christian Münz, University of Zürich, Switzerland.- Therapy of EBV associated diseases.- Chap. 15. Adoptive T cell immunotherapy – Stephen Gottschalk and Cliona Rooney, Baylor College of Medicine, Houston, USA.- Chap. 16. The Development of Prophylactic and Therapeutic EBV Vaccines – Corey Smith and Rajiv Khanna, Queensland Institute of Medical Research, Brisbane, Australia.- Chap. 17. The biology and clinical utility of EBV monitoring in blood– Jennifer Kanakry and Richard Ambinder, Johns Hopkins University, Baltimore, USA.- Index.

Textul de pe ultima copertă

Epstein Barr virus (EBV) was discovered as the first human tumor virus around 50 years ago. Since its discovery in Burkitt’s lymphoma it has been associated with various other malignancies, infectious mononucleosis and even autoimmune diseases. The two book volumes on EBV summarize the first 50 years of research on this tumor virus, starting with historical perspectives on discovery, oncogenicity and immune control, reviewing the role that the virus plays in the various associated diseases and concluding with a discussion on how the immune system keeps persistent EBV infection under control in healthy EBV carriers and can be used to treat EBV associated diseases. The respective 32 chapters are written by international experts from three continents for health care providers, biomedical researchers and patients that are affected by EBV. The assembled knowledge should help to understand EBV associated diseases better and to develop EBV specific vaccination in the near future.

Caracteristici

Historical reminiscence of Professor Sir Anthony Epstein on the discovery of EBV 50 years ago 32 comprehensive chapters on EBV virology, tumorigenesis and immune control Newest insights on EBV strain variation, the recombinant EBV system and in vivo models of infection Comprehensive account of EBV associated diseases, including autoimmune diseases Update on EBV specific therapies including adoptive T cell transfer and new vaccine formulations Includes supplementary material: sn.pub/extras